Meds Apotek Valuation Multiples

Discover revenue and EBITDA valuation multiples for Meds Apotek and similar public comparables like Upexi, YES24, CarParts.com, LightInTheBox and more.

Meds Apotek Overview

About Meds Apotek

Meds Apotek AB (publ) is a full-scale online pharmacy that sells prescription and over-the-counter medicines with permission from the Swedish Medicines Agency. The company's pharmacy products include everything in health, well-being, dietary supplements, beauty, skin care, and animal medicines.


Founded

2017

HQ

Sweden

Employees

N/A

Website

meds.se

Financials (FY)

Revenue: $105M
EBITDA: $2M

EV

$48M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Meds Apotek Financials

Meds Apotek reported last fiscal year revenue of $105M and EBITDA of $2M.

In the same fiscal year, Meds Apotek generated $29M in gross profit, $2M in EBITDA, and $807K in net income.


Meds Apotek P&L

In the most recent fiscal year, Meds Apotek reported revenue of $105M and EBITDA of $2M.

Meds Apotek is profitable as of last fiscal year, with gross margin of 28%, EBITDA margin of 2%, and net margin of 1%.

See analyst estimates for Meds Apotek
Last FY202320242025202620272028
Revenue$105M$68M$87M$105M
Gross Profit$29M$20M$24M$29M
Gross Margin28%29%28%28%
EBITDA$2M($3M)$1M$2M
EBITDA Margin2%(4%)2%2%
EBIT Margin(0%)(8%)(1%)(0%)
Net Profit$807K($5M)($1M)$807K
Net Margin1%(8%)(1%)1%

Financial data powered by Morningstar, Inc.

Meds Apotek Stock Performance

Meds Apotek has current market cap of $55M, and enterprise value of $48M.


Meds Apotek's stock price is $2.94.

Meds Apotek has an EPS (earnings per share) of $0.04.

See more trading valuation data for Meds Apotek
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$48M$55M-0.6%---$0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Meds Apotek Valuation Multiples

Meds Apotek trades at 0.5x EV/Revenue multiple, and 25.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Meds Apotek

Meds Apotek Financial Valuation Multiples

As of August 14, 2026, Meds Apotek has market cap of $55M and EV of $48M.

Meds Apotek has a P/E ratio of 67.8x.

Last FY202320242025202620272028
EV/Revenue0.5x0.7x0.6x0.5x
EV/EBITDA25.2x(17.0x)33.9x25.2x
EV/EBIT(183.5x)(9.3x)(54.7x)(183.5x)
EV/Gross Profit1.7x2.5x2.0x1.7x
P/E67.8x(10.3x)(50.3x)67.8x
EV/FCF(15.9x)(7.9x)38.1x(15.9x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Meds Apotek Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Meds Apotek Margins & Growth Rates

In the most recent fiscal year, Meds Apotek reported gross margin of 28%, EBITDA margin of 2%, and net margin of 1%.

See estimated margins and future growth rates for Meds Apotek

Meds Apotek Margins

Last FY20242025202720282029
Gross Margin28%28%28%
EBITDA Margin2%2%2%
EBIT Margin(0%)(1%)(0%)
Net Margin1%(1%)1%
FCF Margin(3%)1%(3%)

Meds Apotek Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth27%21%
Gross Profit Growth24%20%
EBITDA Growth(150%)34%
EBIT Growth(83%)(70%)
Net Profit Growth(80%)(174%)
FCF Growth(121%)(339%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Meds Apotek Operational KPIs

Access forward-looking KPIs for Meds Apotek
Last FY202320242025202620272028
Opex to Revenue28%36%29%28%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Meds Apotek Competitors

Meds Apotek competitors include Upexi, YES24, CarParts.com, LightInTheBox, KT Millie Seojae, Auto.de, d1000, Talea Group, Sportsman's Warehouse and Waqoo.

Most Meds Apotek public comparables operate across Pharmacies, Consumer E-commerce and Vertical E-commerce.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Upexi18.6x11.1x(24.3x)-
YES240.3x-137.9x-
CarParts.com0.1x0.1x(2.3x)(15.2x)
LightInTheBox0.2x0.2x4.9x4.1x
KT Millie Seojae0.1x-0.5x-
Auto.de--440.6x-
d10000.3x-3.9x-
Talea Group0.6x-24.4x-

This data is available for Pro users. Sign up to see all Meds Apotek competitors and their valuation data.

Start Free Trial

Meds Apotek VC Funding History

Before going public, Meds Apotek raised $26M in total equity funding, across 4 rounds.


Meds Apotek Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Nov-19Undisclosed stageMåns Zelmerlöw$16M--
Jan-19Series ACNI Nordic 5; Inbox Capital$6M-Meds Apotek is a Stockholm-based online pharmacy founded in 2017 that sells beauty and health care products as well as non-prescription medications. On November 1, 2019, the company raised $5.73 million in a funding round with investors including CNI Nordic 5 (listed as Club Network), Inbox Capital, Centripetal, and M2 Asset Management. This round brought Meds Apotek's total funding to $5.73 million.
Mar-18Seed-$4M-Meds Apotek is a Stockholm-based online pharmacy founded in 2017 that sells prescription and over-the-counter medicines, beauty, and health care products with direct delivery and no physical stores. The company raised $5.73M in a funding round on January 11, 2019, led by investors including Inbox Capital. Investors also include Club Network, Centripetal, and M2 Asset Management.
Jul-17Pre-seed-$1M--

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Meds Apotek

When was Meds Apotek founded?Meds Apotek was founded in 2017.
Where is Meds Apotek headquartered?Meds Apotek is headquartered in Sweden.
Is Meds Apotek publicly listed?Yes, Meds Apotek is a public company listed on Nasdaq Stockholm.
What is the stock symbol of Meds Apotek?Meds Apotek trades under MEDS ticker.
When did Meds Apotek go public?Meds Apotek went public in 2022.
Who are competitors of Meds Apotek?Meds Apotek main competitors include Upexi, YES24, CarParts.com, LightInTheBox, KT Millie Seojae, Auto.de, d1000, Talea Group, Sportsman's Warehouse, Waqoo.
What is the current market cap of Meds Apotek?Meds Apotek's current market cap is $55M.
What is the current revenue of Meds Apotek?Meds Apotek's last fiscal year revenue is $105M.
What is the current EV/Revenue multiple of Meds Apotek?Current revenue multiple of Meds Apotek is 0.5x.
Is Meds Apotek profitable?No, Meds Apotek is not profitable.
How many companies Meds Apotek has acquired to date?Meds Apotek hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Meds Apotek has invested to date?Meds Apotek hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Meds Apotek

Lists including Meds Apotek

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial